Comparing Two Heart Medicines for Heart Failure
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two heart medicines, carvedilol and metoprolol succinate, for people with a certain type of heart failure. It aims to see if they work just as well as each other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have heart failure symptoms like shortness of breath, fatigue, or leg swelling.
- Your heart's pumping ability (ejection fraction) is 40% or less.
- You are able to take either carvedilol or metoprolol succinate (no allergies or medical reasons against them).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two common heart medicines, bisoprolol and verapamil, improve symptoms in adults with non-obstructive hypertrophic cardiomyopathy. It may help you and your care team understand which medicine works better for symptom control and heart function.
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
This study tests whether the heart medication metoprolol can help people who have both heart failure with reduced pumping function and COPD (a lung condition). It aims to see if the drug is safe and effective for this combination of conditions.
This study compares three different combinations of medicines to see which one works best for people with heart failure and a preserved ejection fraction (a type of heart failure where the heart's pumping function is normal but it doesn't fill properly). Participants will receive one of three treatments: vicadrostat plus empagliflozin, empagliflozin alone, or empagliflozin plus spironolactone. The study looks at how these medicines affect proteins in the blood, which may help doctors understand which treatment is more effective.
This trial tests which heart medications work best for older adults who have stable angina (predictable chest pain) and multiple other long-term health problems. You may be asked to start or adjust medications and attend regular follow-up visits to see which approach controls symptoms and outcomes.
This phase 3 study tests whether a specific beta blocker selection on hemodialysis can improve cardiovascular outcomes. It focuses on certain beta blockers commonly used through the VA pharmacy and compares them in a randomized way.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.